Successive Efficacy Evaluation of Various Commercial Live-Attenuated Avian coronavirus Vaccination Schedules Against a Local GI-23.3 Challenge in SPF Broilers

<b>Background:</b><i>Infectious bronchitis virus</i> (IBV) is a highly spreading, evolving virus that induces multiple manifestations, including respiratory, urinary, and reproductive symptoms, and presents a considerable risk to the Egyptian poultry sector. This study assessed various IBV vaccination protocols available in broiler populations comprising live attenuated vaccines such as IB Var II, 793/B (4/91), IB Primer, and H120 against the local novel IBV-GI-23.3 strain. <b>Methods:</b> Vaccines were administered to eight groups of SPF chicks at 1 day only or 1 + 14 days of age. Birds were challenged via the oculo-nasal route at 28 days of age using 10<sup>6</sup> EID<sub>50</sub>/0.2 mL/chick with the NewValley-1-EGYIBV-GI23.3-2023 local strain. Ciliostasis activity and the scores for histopathological lesions were evaluated at 7 days post-challenge (DPC). Virus shedding was monitored at 3, 5, and 7 DPC using the real-time RT-PCR method. <b>Results:</b> The ciliostasis test indicated that the vaccinated groups receiving the IB Primer + 4/91 vaccine regime at 1 day only or 1 + 14 days of age received the highest level of protection (65%, 68%, respectively). Similarly, administration of IB Primer + IB Var II at 1 + 14 days of age demonstrated substantial protection (63%). Conversely, administering the H120 + 4/91 vaccination protocol at days 1 and 14 resulted in a moderate level of protection (53%). Tracheal IBV shedding quantification and subsequent histopathological signs of trachea, proventriculus, bursa, and kidney degenerative changes were significantly lower in the vaccinated groups (especially the IB Primer + 4/91 vaccine regime at 1 day only or 1 + 14 days) than in the positive control groups. <b>Conclusions:</b> The heterologous combined IB Primer + 4/91 program demonstrated the most significant protective efficacy against the IBV field challenge strains compared with other vaccines in broiler chickens.

Authors

Institutions

Publication Details

Journal
Vaccines
Published
2025-11-02
DOI
https://doi.org/10.3390/vaccines13111132
Citations
1
Primary Topic
Animal Virus Infections Studies
Type
article
Field-Weighted Citation Impact
1.19
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Successive Efficacy Evaluation of Various Commercial Live-Attenuated Avian coronavirus Vaccination Schedules Against a Local GI-23.3 Challenge in SPF Broilers

Abd Elfattah Ibrahim El-Zanaty, Ali Zanaty, Karim Selim, Ibrahim Eldaghayes et al.
1 citations
Vaccines
Animal Virus Infections Studies
1.19
article

Successive Efficacy Evaluation of Various Commercial Live-Attenuated Avian coronavirus Vaccination Schedules Against a Local GI-23.3 Challenge in SPF Broilers

Abd Elfattah Ibrahim El-Zanaty, Ali Zanaty, Karim Selim, Ibrahim Eldaghayes, Eman A. M. Shosha, Sara Abdelnaser
article en
1 citations

Abstract

<b>Background:</b><i>Infectious bronchitis virus</i> (IBV) is a highly spreading, evolving virus that induces multiple manifestations, including respiratory, urinary, and reproductive symptoms, and presents a considerable risk to the Egyptian poultry sector. This study assessed various IBV vaccination protocols available in broiler populations comprising live attenuated vaccines such as IB Var II, 793/B (4/91), IB Primer, and H120 against the local novel IBV-GI-23.3 strain. <b>Methods:</b> Vaccines were administered to eight groups of SPF chicks at 1 day only or 1 + 14 days of age. Birds were challenged via the oculo-nasal route at 28 days of age using 10<sup>6</sup> EID<sub>50</sub>/0.2 mL/chick with the NewValley-1-EGYIBV-GI23.3-2023 local strain. Ciliostasis activity and the scores for histopathological lesions were evaluated at 7 days post-challenge (DPC). Virus shedding was monitored at 3, 5, and 7 DPC using the real-time RT-PCR method. <b>Results:</b> The ciliostasis test indicated that the vaccinated groups receiving the IB Primer + 4/91 vaccine regime at 1 day only or 1 + 14 days of age received the highest level of protection (65%, 68%, respectively). Similarly, administration of IB Primer + IB Var II at 1 + 14 days of age demonstrated substantial protection (63%). Conversely, administering the H120 + 4/91 vaccination protocol at days 1 and 14 resulted in a moderate level of protection (53%). Tracheal IBV shedding quantification and subsequent histopathological signs of trachea, proventriculus, bursa, and kidney degenerative changes were significantly lower in the vaccinated groups (especially the IB Primer + 4/91 vaccine regime at 1 day only or 1 + 14 days) than in the positive control groups. <b>Conclusions:</b> The heterologous combined IB Primer + 4/91 program demonstrated the most significant protective efficacy against the IBV field challenge strains compared with other vaccines in broiler chickens.

VaccinesVol. 13(11)
South Valley University (EG), University of Tripoli (LY), Animal Health Research Institute (TW)
Openalex Percentile: Top 18%
Animal Virus Infections Studies
1.19
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.